Clinical and pharmacokinetic results of upadacitinib in Chinese healthy subjects and subjects with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Zheng, Min [1 ]
Zhang, Chunlei [2 ]
Fang, Hong [3 ]
机构：
[1] Zhejiang Univ, Dept Dermatol, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China
[2] Peking Univ Third Hosp, Dept Dermatol, Beijing, Peoples R China
[3] Zhejiang Univ, Dept Dermatol, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
32333
引用
收藏
页码：AB30 / AB30
页数：1
相关论文
共 50 条
  • [1] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [2] The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients
    Li, Lu
    Wu, Naming
    Liu, Tingyu
    Yu, Guoqun
    Wang, Yifei
    He, Ting
    Mao, Raymond
    Yang, Liu
    Li, Yan
    Shen, Chen
    Tao, Juan
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [3] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [4] Upadacitinib for moderate to severe atopic dermatitis
    Navarro-Trivino, Francisco
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Ruiz-Villaverde, Ricardo
    Pereyra-Rodriguez, Jose-Juan
    Armario-Hita, Jose-Carlos
    [J]. IMMUNOTHERAPY, 2023, 15 (11) : 799 - 808
  • [5] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
    Zhao, Dan-Jie
    Li, Xia
    Lin, Hai-Xia
    Zheng, Hong
    Zhou, Di
    Tang, Peng
    [J]. PLOS ONE, 2024, 19 (07):
  • [6] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
    Meher, Bikash R.
    Mishra, Archana
    Behera, Biswanath
    Ponnusamy, Subashri
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [7] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    [J]. JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [8] Oral difelikefalin improves itch and inflammatory biomarkers in atopic dermatitis subjects with moderate-to-severe pruritus
    Guttman-Yassky, E.
    Facheris, P.
    Da Rosa, J. Correa
    Del Duca, E.
    Estrada, Y.
    David, E.
    Pavel, A.
    Bose, S.
    Goncalves, J.
    Nograles, K.
    Kim, B.
    Lebwohl, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [9] Oral difelikefalin improves itch and inflammatory biomarkers in subjects with atopic dermatitis with moderate-to-severe pruritus
    Guttman-Yassky, Emma
    Facheris, Paola
    Da Rosa, Joel Correa
    Estrada, Yeriel
    David, Eden
    Pavel, Ana
    Bose, Swaroop
    Goncalves, Joana
    Nograles, Kristine
    Kim, Brian
    Lebwohl, Mark
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E116 - E116
  • [10] Upadacitinib normalizes the lesional and nonlesional cutaneous transcriptome in patients with moderate-to-severe atopic dermatitis
    Smith, K. M.
    Chen, X.
    Tsoi, L. C.
    Bi, Y.
    Gudjonsson, J.
    Parmentier, J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S138 - S138
12345